Pirfenidone attenuates fibrocyte mobilization in bleomycin-induced pulmonary fibrosis in mice by reducing Ccl2 production in vivo and fibrocyte migration in vitro [145]. The gene discussed is CCL2; the disease is pulmonary fibrosis.